Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Sufentanil Tablet System for Patient-Controlled Analgesia After Total Knee Arthroplasty
2019-001232-59Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil in postoperative pain and pain, sponsored by Ghent University Hospital. Primary endpoint: Cumulative time with NRS < 4 during 48 hours postoperatively. Started Nov 2019; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on 2019-001232-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001232-59.